Home > Insider Trading > Filing (0001209191-19-011333)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1343304	Avedro Inc	AVDR	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1435183	Garheng Kong	C/O Avedro, Inc. 201 Jones Road Waltham MA 02451		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2019-02-19	87,663	$0.00	197,197	No	4	C	Indirect	See Footnote
Common Stock	Acquisiton	2019-02-19	561,673	$0.00	758,870	No	4	C	Indirect	See Footnote
Common Stock	Acquisiton	2019-02-19	535,369	$0.00	1,294,239	No	4	C	Indirect	See Footnote
Common Stock	Acquisiton	2019-02-19	142,857	$14.00	1,437,096	No	4	P	Indirect	See Footnote

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	C	Indirect	See Footnote
No	4	C	Indirect	See Footnote
No	4	C	Indirect	See Footnote
No	4	P	Indirect	See Footnote

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Series AA Convertible Preferred Stock	Disposition	2019-02-19	87,663	$0.00	87,663	$0.00
Common Stock	Series BB Convertible Preferred Stock	Disposition	2019-02-19	561,673	$0.00	561,673	$0.00
Common Stock	Series CC Convertible Preferred Stock	Disposition	2019-02-19	535,369	$0.00	535,369	$0.00
Common Stock	Stock Option (right to buy)	Acquisiton	2019-02-19	8,314	$0.00	8,314	$12.73

Remaning Holdings	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0		No	4	C	Indirect
0		No	4	C	Indirect
0		No	4	C	Indirect
8,314	2029-01-08	No	4	A	Direct

Footnotes

Each share of Series AA Convertible Preferred Stock, Series BB Convertible Preferred Stock and Series CC Convertible Preferred Stock was convertible at any time, at the option of the holder, into Common Stock, on a one-for-one basis, had no expiration date and converted into shares of Common Stock upon the closing of the Issuer's initial public offering.
The shares are directly held by HealthQuest Partners II, L.P. ("HealthQuest"). HealthQuest Venture Management II, L.L.C. ("HealthQuest Management") is the general partner of HealthQuest. HealthQuest Management may be deemed to have voting and dispositive power over the shares held by HealthQuest. The Reporting Person is the managing member of HealthQuest Management and disclaims beneficial interest over all of the shares held by HealthQuest except to the extent of his pecuniary interest therein.
One hundred percent (100%) of the shares subject to the option shall vest on the earlier of (x) June 1, 2020 and (y) the first anniversary of the first annual meeting of the Issuer's stockholders following the Issuer's initial public offering, subject to the Reporting Person continuing to provide service through such date.